Unlike in MDD, where the serotonin 1A receptor subtype (5-HT1A) has commonly been used to study pathophysiological alterations, treatment-resistant depression (TRD) subjects represent a less investigated cohort. This evidence concerns the gene HTR1A and depressive symptom measurement.